SCHEMBL8434004

SCHEMBL8434004

C=CCNc1ncccc1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
RAB9A P51151 1/20 0.49
SUMO3 P55854 1/20 0.46
SUMO2 P61956 1/20 0.46
SUMO1 P63165 1/20 0.46
KDM4E B2RXH2 5/20 0.42
LMNA P02545 3/20 0.42
HTT P42858 3/20 0.42
RRM2 P31350 1/20 0.42
HIF1A Q16665 1/20 0.42
ALDH1A1 P00352 5/20 0.41
HPGD P15428 2/20 0.41
SLC2A1 P11166 1/20 0.40
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7361533 0.79 BACE1 (0.38) SMN1; SMN2MEN1KMT2AGAAMAPT
SCHEMBL7361532 0.79 BACE1 (0.38) SMN1; SMN2MEN1KMT2AGAAMAPT
SCHEMBL11263883 0.79 ALDH1A1 (0.45) MAPTRAB9AKDM4EALDH1A1HPGD
SCHEMBL2814675 0.79 ALDH1A1 (0.49) SMN1; SMN2MEN1KMT2AGAAMAPT
SCHEMBL21782258 0.76 SMN1; SMN2 (0.43) SMN1; SMN2MEN1KMT2AGAAMAPT
SCHEMBL3825817 0.76 GRM5 (0.43) GAAMAPTKDM4EALDH1A1HPGD
SCHEMBL11578570 0.76 GRM5 (0.43) GAAMAPTKDM4EALDH1A1HPGD
SCHEMBL3805672 0.75 KDM4E (0.45) SMN1; SMN2MEN1KMT2AGAAMAPT
SCHEMBL2230165 0.75 SUMO3 (0.43) SMN1; SMN2MEN1KMT2AGAAMAPT
SCHEMBL9432628 0.75 RAB9A (0.50) SMN1; SMN2MEN1KMT2AGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0429987-B1 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1999-03-17 EP disclosed
US-5837704-A PREVENTION OR TREATMENT OF AIDS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1998-11-17 US disclosed
EP-0745083-B1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO [3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION BOEHRINGER INGELHEIM PHARMA (US) 1998-05-20 EP disclosed
US-5620974-A ENZYME INHIBITOR, TREATS ACQUIRED IMMUNE DEFICIENCY SYNDROME(AIDS) BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1997-04-15 US disclosed
EP-0745083-A1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO [3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1996-12-04 EP disclosed
WO-1995022545-A1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO[3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1995-08-24 WO disclosed
US-5366972-A 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1994-11-22 US disclosed